14 results · 29ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

DURAMATRIX COLLAGEN DURA SUBSTITUTE MEMBRANE - ONLAY AND SUTURABLE

FDA 510(k)
FDA Class 2 ·Neurology

CORRESTORE PATCH, MODELS 1.5P2, 2P3, 3P4; CORRESTORE SIZER, MODEL CRPS

FDA 510(k)
FDA Class 2 ·Cardiovascular

HARDYDISK CINOXACIN, 100 MCG

FDA 510(k)
FDA Class 2 ·Microbiology

LIFESTENT FLEXSTAR XL BILIARY STENT

FDA Adverse Event
Injury ·ANGIOMED GMBH & CO.·Product code FGE·November 21, 2008

LIFESTENT FLEXSTAR XL BILIARY STENT

FDA Adverse Event
Malfunction ·ANGIOMED GMBH & CO.·Product code FGE·November 5, 2008

LIFESTENT FLEXSTAR XL BILIARY STENT

FDA Adverse Event
Malfunction ·ANGIOMED GMBH & CO. MEDIZINTECHNIK·Product code FGE·February 20, 2009

LIFESTENT FLEXSTAR XL BILIARY STENT

FDA Adverse Event
Malfunction ·ANGIOMED GMBH & CO.·Product code FGE·November 4, 2008

LIFESTENT FLEXSTAR XL BILIARY STENT

FDA Adverse Event
Malfunction ·ANGIOMED GMBH & CO, MEDIZINTECHNIK·Product code FGE·February 13, 2009

SETROX S 60

FDA Adverse Event
BIOTRONIK SE & CO. KG·Product code NVN·April 16, 2013

VASOVIEW HEMOPRO 2 EVH SYSTEM

FDA Adverse Event
Malfunction ·MAQUET CARDIOVASCULAR, LLC·Product code GEI·March 16, 2011

CELLSEARCH CIRCULATING TUMOR CELL KIT

FDA Adverse Event
Malfunction ·VERIDEX LLC·Product code NQI·June 16, 2008

Belmont Rapid Infuser, a Fluid Management System, Model FMS2000.

FDA Enforcement
Class II ·Terminated·Belmont Instrument Corporation·October 24, 2012

Roche cobas 8000 modular analyzer series (i.e., cobas 8000 ISE module; cobas c 502, 701, and 702 modules; and cobas e 602 and 801 modules). Chemistry Analyzer (photometric discrete), for clinical use Part Number: 08763662001

FDA Enforcement
Class II ·Ongoing·Roche Diagnostics Operations, Inc.·January 6, 2021

CADD¿- Solis Ambulatory Infusion Pump, Model 2111 & 2112, Version 1.0, Version 2.0 and Version 3.0 & Model 2120, Version 1.0. Provide measured drug therapy to patients in hospital or outpatient settings.

FDA Enforcement
Class II ·Terminated·Smiths Medical ASD, Inc.·June 24, 2015